Valuation: GKB Ophthalmics Limited

Market Cap 322M 3.37M 2.89M 2.7M 2.48M 4.66M 4.74M 31.88M 12.48M 162M 12.66M 12.39M 535M P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 395M 4.13M 3.54M 3.31M 3.03M 5.71M 5.8M 39.03M 15.28M 198M 15.51M 15.17M 655M EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
12/08 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
28/05 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
13/02 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
15/11 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
31/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
15/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
15/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day+0.42%
1 week+6.60%
Current month+10.26%
1 month+11.63%
3 months+0.63%
6 months+8.26%
Current year+24.80%
1 week 60
Extreme 60
69.95
1 month 55
Extreme 55
69.95
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 57 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+6.60%-22.92%-27.37% 3.35M
-0.27%-0.58%-39.86%-6.57% 87.21B
-1.59%+0.27%-17.94%-18.97% 35.89B
+1.44%+0.22%+3.88%-17.33% 14.78B
+1.78%+8.55% - - 11.4B
-5.46%+6.36%-8.35%+653.73% 2.51B
-2.75%-7.12%-43.06%-59.44% 1.49B
-2.53%-4.94%+56.34%-6.38% 918M
-3.07%-3.97%-40.86%-22.72% 883M
+3.87%-0.66%+18.27%+10.44% 869M
Average -0.77%-0.17%-10.50%+56.15% 15.6B
Weighted average by Cap. -0.26%-2.51%-28.48%+0.17%

Financials

2025 2026
Net sales 1.09B 11.4M 9.78M 9.13M 8.38M 15.76M 16.02M 108M 42.2M 547M 42.81M 41.88M 1.81B 1.49B 15.6M 13.38M 12.49M 11.46M 21.55M 21.91M 147M 57.72M 748M 58.56M 57.28M 2.47B
Net income -70.45M -737K -632K -590K -542K -1.02M -1.04M -6.97M -2.73M -35.33M -2.77M -2.71M -117M 12.18M 127K 109K 102K 93.69K 176K 179K 1.2M 472K 6.11M 479K 468K 20.21M
Net Debt 15.59M 163K 140K 131K 120K 225K 229K 1.54M 604K 7.82M 612K 599K 25.85M 72.38M 757K 650K 607K 557K 1.05M 1.06M 7.16M 2.8M 36.3M 2.84M 2.78M 120M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
19/08/26 INR 63.95 +0.42% 2,903
18/08/26 INR 63.68 -2.03% 274
17/08/26 INR 65.00 0.00% 2,236
14/08/26 INR 65.00 +0.02% 18,890
13/08/26 INR 64.99 +5.80% 5,318